Cargando…
A Model Based Cost-Effectiveness Analysis of Routine Genotyping for CYP2D6 among Older, Depressed Inpatients Starting Nortriptyline Pharmacotherapy
OBJECTIVE: Genotyping for CYP2D6 has the potential to predict differences in metabolism of nortriptyline. This information could optimize pharmacotherapy. We determined the costs and effects of routine genotyping for old aged Dutch depressed inpatients. METHODS: With a decision-tree, we modelled the...
Autores principales: | Berm, Elizabeth J. J., Gout-Zwart, Judith J., Luttjeboer, Jos, Wilffert, Bob, Postma, Maarten J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5199075/ https://www.ncbi.nlm.nih.gov/pubmed/28033366 http://dx.doi.org/10.1371/journal.pone.0169065 |
Ejemplares similares
-
Effects and cost-effectiveness of pharmacogenetic screening for CYP2D6 among older adults starting therapy with nortriptyline or venlafaxine: study protocol for a pragmatic randomized controlled trial (CYSCEtrial)
por: Berm, Elizabeth JJ, et al.
Publicado: (2015) -
Budget Impact Analysis of Metformin Sustained Release for the Treatment of Type 2 Diabetes in The Netherlands
por: Gout-Zwart, Judith J., et al.
Publicado: (2019) -
Budget Impact Analysis of a Renal Point-of-Care Test in Dutch Community Pharmacies to Prevent Antibiotic-Related Hospitalizations
por: Gout-Zwart, Judith J., et al.
Publicado: (2018) -
Economic Evaluations of Pharmacogenetic and Pharmacogenomic Screening Tests: A Systematic Review. Second Update of the Literature
por: Berm, Elizabeth J. J., et al.
Publicado: (2016) -
Amitriptyline/nortriptyline: Lack of efficacy: case report
Publicado: (2022)